LSB INDUSTRIES, INC. (LXU) is held by 2 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding versus the previous quarter. Insiders were net buyers over the last 90 days ($32.5K bought vs $0 sold). Latest close $9.57 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 16, 2026 · Congress to Nov 16, 2026.
Third Avenue Management · First Eagle Investment Management — 2 tracked funds hold LXU. See all holders.
Insiders bought on the open market (3 purchases, $32.5K) vs 0 sales ($0). Latest buy: Nov 16, 2026. Insider trading
LINDE PLC (LIN) · Air Products & Chemicals, Inc. (APD) · LUXFER HOLDINGS PLC (LXFR) · Merck & Co., Inc. (MRK) · ELI LILLY & Co (LLY) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Third Avenue Management | 0.66% | 381,096 | HELD Q3 filed Nov 13 |
| First Eagle Investment Management | 0.03% | 1,418,900 | ADDED (+30.8%) Q3 filed Nov 10 |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: -0.8% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 200 of 8,857 filers |
| Long-only filers among them | 200 |
| Change vs 2026 Q1 | +15 net · 192 entered · 177 exited |
| Shares reported, all filers | 49,980,329 |
| Reported value, all filers | $522.3M |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | NYSE |
| Industry | Industrial Inorganic Chemicals (SIC 2810) |
| Revenue · FY2025 | $615.2M |
| Net income · FY2025 | $24.6M |
| Total assets · FY2025 | $1.2B |
| Shares outstanding | 72,002,670 |
| Market cap (at latest close) | $689.1M |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Oct 23, 2026.
| Shares short · Oct 15, 2026 | 3,648,311 |
| Share of shares outstanding | 5.07% |
| Days to cover | 5.11 |
Shares short at recent settlements — Jul 31, 2026: 3.0M · Aug 14, 2026: 3.4M · Aug 31, 2026: 3.4M · Sep 15, 2026: 3.8M · Sep 30, 2026: 3.8M · Oct 15, 2026: 3.6M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Oct 23, 2026.
| Shares failed to deliver · Oct 14, 2026 | 0 |
| Share of shares outstanding | 0.00% |
| Fails as a share of short interest · Oct 15, 2026 | 0.0% |
Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Oct 23, 2026.
1 insider bought on the open market in the last 90 days (3 purchases, $32.5K), against 0 sales by 0 insiders ($0). Latest buy: Nov 16, 2026.
Source: SEC Form 4 filings. Open-market transactions only.
Recent open-market trades
| Date | Insider | Role | Buy / Sell | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Ackerman Jonathan Z. | Buy | 1,000 | $11.08 | $11.1K | SEC filing | |
| Oct 15, 2026 | Ackerman Jonathan Z. | Buy | 1,000 | $10.17 | $10.2K | SEC filing | |
| Sep 15, 2026 | Ackerman Jonathan Z. | Buy | 1,000 | $11.30 | $11.3K | SEC filing |
Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.
| Filed | Seller | Role | Shares to sell | Market value | Approx. sale date | Source |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | White Lynn F | Director | 40,000 | $471.9K | Jun 10, 2026 | SEC filing |
| Jun 8, 2026 | CARVER KRISTY | Officer | 9,554 | $120.7K | Jun 8, 2026 | SEC filing |
| Mar 26, 2026 | Todd L. Boehly | 10% Stockholder | 4,889,159 | $72.6M | Mar 26, 2026 | SEC filing |
| Mar 12, 2026 | CHERYL MAGUIRE | Officer | 20,000 | $270.0K | Mar 12, 2026 | SEC filing |
| Mar 2, 2026 | BEHRMAN MARK T | Officer | 250,000 | $2.9M | Mar 2, 2026 | SEC filing |
| Feb 26, 2026 | CARVER KRISTY | Officer | 2,091 | $23.0K | Feb 26, 2026 | SEC filing |
| Jan 14, 2026 | CARVER KRISTY | Officer | 19,550 | $195.3K | Jan 14, 2026 | SEC filing |
| Jan 14, 2026 | CHERYL MAGUIRE | Officer | 15,000 | $144.6K | Jan 14, 2026 | SEC filing |
| Jan 14, 2026 | BARRY H GOLSEN 2007 IRREV TR U/A DTD 01/15/2007 | Director | 50,154 | $483.5K | Jan 14, 2026 | SEC filing |
| Jan 14, 2026 | BGG FAMILY LLC | Director | 132,611 | $1.3M | Jan 14, 2026 | SEC filing |
A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.
| Filed | Form | Price change since disclosure |
|---|---|---|
| Mar 30, 2026 | SCHEDULE 13D/A | -29.1% (close Mar 31, 2026 → Nov 17, 2026) |
Reference close is the first trading day after the filing (Mar 31, 2026). A Schedule 13D reports beneficial ownership, not a purchase — there is no transaction price to show. Source: SEC EDGAR Schedule 13D filings.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Apr 27, 2026 | BlackRock, Inc. | SC 13G/A | 3,997,366 | 5.6% | Mar 31, 2026 | SEC filing |
| Mar 30, 2026 | Todd L. Boehly | SC 13D/A | 10,417,768 | 14.5% | Mar 26, 2026 | SEC filing |
| Feb 17, 2026 | CastleKnight Master Fund LP | SC 13G/A | 3,239,383 | 4.5% | Dec 31, 2025 | SEC filing |
| Dec 23, 2025 | ROBOTTI ROBERT | SC 13D/A | 3,528,347 | 4.9% | Dec 19, 2025 | SEC filing |
| Oct 10, 2025 | CastleKnight Master Fund LP | SC 13G | 4,917,905 | 6.8% | Oct 3, 2025 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).
Industry: Industrial Inorganic Chemicals (SIC 2810). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Lobbying: 20 Lobbying Disclosure Act filings named this company as client, 2012–2021; most common issues: Homeland Security (15), Small Business (3), Chemicals/Chemical Industry (1).
Federal contracts: $73.8K in obligated amounts, fiscal years 2021–2026.
| Fiscal year | Obligated amount |
|---|---|
| FY2021 | $-222.6K |
| FY2022 | $296.4K |
| FY2023 | $0 |
| FY2024 | $0 |
| FY2025 | $0 |
| FY2026 | $0 |
Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.
Insiders
· Insider Net Buying — Last 90 days: more insider buy transactions than sell transactions
Financial Screens
· Piotroski — Financial health improved over the past year
Red Flags
· Auditor Change (8-K 4.01) — Last 2 years: an auditor change filing (8-K Item 4.01)
Key figures
· Piotroski — F-score: 7 · Return on assets: 2.1% · Operating cash flow: $95.5M
· Insider Net Buying — Buy txns: 3 · Sell txns: 0 · Buy value: $32.5K · Latest buy: Nov 16, 2026
· Auditor Change (8-K 4.01) — Latest event: Mar 9, 2026 · Events in 2 yrs: 1
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
Also held by the tracked funds that hold LXU — ranked by lift, the co-holding pattern described in Methodology: LINDE PLC (LIN) · Air Products & Chemicals, Inc. (APD) · LUXFER HOLDINGS PLC (LXFR) · Merck & Co., Inc. (MRK) · ELI LILLY & Co (LLY) · PROCTER & GAMBLE Co (PG) · PFIZER INC (PFE) · AbbVie Inc. (ABBV).
8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.
| Filed | Items | Source |
|---|---|---|
| Oct 29, 2026 | 9.01 Financial Statements and Exhibits | SEC filing |
| Oct 28, 2026 | 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits | SEC filing |
| Sep 9, 2026 | 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
LINDE PLC (LIN) · Track Record: how the signals scored · Practice timing on LXU
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.